Evidence map›Paper›PMID 40630608›Full record

ReviewEClinicalMedicine2025

Beyond behavioural change: prioritising structural solutions to control bacterial sexually transmitted infections.

Jason J Ong, Magnus Unemo, Jean-Michel Molina, Angelica E Miranda, Kate L Seib, Maeve Brito de Mello, Meg Doherty, Cheryl C Johnson, Sinead Delany-Moretlwe, Christopher Fairley

Abstract readReview
In one paragraph

Review in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jason J OngSchool of Translational Medicine, Monash University, Melbourne, Australia.
Magnus UnemoWHO Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Sweden.
Jean-Michel MolinaUniversity of Paris, France.
Angelica E MirandaFederal University of Espirito Santo, Brazil.
Kate L SeibInstitute for Biomedicine and Glycomics, Griffith University, Australia.
Maeve Brito de MelloWHO Global HIV, Hepatitis and STIs Programmes, Switzerland.
Meg DohertyWHO Global HIV, Hepatitis and STIs Programmes, Switzerland.
Cheryl C JohnsonWHO Global HIV, Hepatitis and STIs Programmes, Switzerland.
Sinead Delany-MoretlweUniversity of Witwatersrand, South Africa.
Christopher FairleySchool of Translational Medicine, Monash University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With over 374 million new curable bacterial STI cases annually, we are far from meeting global health targets. Despite their serious consequences for sexual, reproductive, and mental health, control efforts often focus on individual-level interventions like condom promotion and behavior change, which are insufficient. A scientific framework for STI control emphasizes reducing infectiousness, decreasing the number of susceptible individuals, and lowering transmission probability. Effective strategies should focus on environmental modifications, including expanding access to quality sexual health care, rapid testing with same-visit treatment, and AI-enhanced diagnostics. Equally critical are protecting susceptible communities through vaccination and chemoprophylaxis (e.g., doxycycline post-exposure prophylaxis). While individual behavioural interventions like condom promotion remain relevant, declining usage trends challenge their impact. Surveillance of STIs and antimicrobial resistance is essential, influencing all key drivers of transmission. To control STIs more effectively, we must shift from individual behaviour change to systems-level public health strategies. Prioritising accessible, stigma-free health services, leveraging technological advances, and investing in comprehensive public health policies will improve STI prevention and help meet global health goals. Funding: JJO, CKF and KS are funded by the Australian National Health and Medical Research Council (GNT1193955, GNT1172900 and GNT2017383, respectively).

Indexed as

DiagnosticsGlobal health strategyPublic health interventionSexually transmitted infections

Identifiers

PMID40630608
PMCPMC12235396

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.